Total Funding
39
Total FundingPrivate Equity raised
Growth Score
pts
Heat Score
-1 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
108176
Koligo therapeutics is a transformational cell therapies for patients with pancreatic disease .
- Stuart Williams: koligo therapeuticsPast Role: Tissue Genesis, chief science officer
- David Blanford: Chief Financial Officer
About the Company
Koligo Therapeutics’ mission is to develop, manufacture, and commercialize transformative cell therapies for the treatment of pancreatic diseases.Koligo is dedicated to supporting their mission while respecting their values.Their employees agree in writing to certain professional standards to codify our mutual understanding of Koligo’s ethics and
conduct .
